CAS: 101251-09-6; 4-Acetylaminophenylboronic Acid

该化合物是一种有机化合物,其特征是存在一种碱酸功能组和一个苯环上的乙酰胺替代物,其分子结构特征是一种苯环,其位置与乙酰胺组和黄酸组相替代,其作用和潜在用途均有助于其在药用化学和材料科学中的再活性和潜在应用;该化合物一般是白色的,是白色的,是非白色的固体,在水和酒精等极溶剂中可溶解;该化合物可能形成与二醇的可逆共价结合. 4-乙酰苯乙酸经常用于各种药物的合成,并用作有机合成的构件,特别是用于开发药物候选体和生物凝聚领域.该化合物与生物分子形成复杂体的能力使其在化学生物学中成为有价值的工具.应当参考安全数据,以便处理和储存,如同所有化学物质一样,用于安全处理和储存.

结构式图片

相似化合物

214360-60-8 78887-39-5 99349-68-5

欧盟法规

C&L通报

上下游产品

4-氨基苯硼酸 (4-Aminophenyl)Boronic Acid 89415-43-0
4′-氨基乙酰苯胺 N-Acetyl-P-Phenylenediamine 122-80-5

合成工艺路线路线简述

    4-乙酰基氨基苯硼酸频哪醇酯置于水体系中,用 乙醇 用作溶剂,化学反应生成4-乙酰胺基苯硼酸
    参考文献:Susceptibility To Hydrolysis Of Phenylboronic Pinacol Esters At Physiological Ph
    标题:Susceptibility To Hydrolysis Of Phenylboronic Pinacol Esters At Physiological Ph
    摘要:摘要:硼酸及其酯是设计新药物和药物输送装置的高度考虑化合物,特别是作为适用于中子俘获疗法的硼载体.然而,这些化合物在水中只具有较小的稳定性.本文描述了一些苯硼酸酯的水解过程.动力学取决于芳香环中的取代基.此外,Ph值强烈影响反应速率,这在生理ph下会显著加快.因此,在考虑将这些硼酸酯用于药理学目的时,必须谨慎对待.
    Doi:10.2478/s11532-012-0159-2

    专利信息


    专利号:US-2012077802-A1
    优先权日:2009-06-10
    标题 :Histamine h3 inverse agonists and antagonists and methods of use thereof
    发明人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN
    权利人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN; SUNOVION PHARMACEUTICALS INC
    摘要:Provided herein are spiro-cyclic compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as, e.g., histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical compositions containing the compounds and their methods of use are also provided herein.

    专利号:US-2012172350-A1
    优先权日:2009-09-11
    标题 :Histamine h3 inverse agonists and antagonists and methods of use thereof
    发明人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN
    权利人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN; SUNOVION PHARMACEUTICALS INC
    摘要:Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as, e.g., histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical compositions containing the compounds and their methods of use are also provided herein.

    专利号:US-8404670-B2
    优先权日:2009-02-11
    标题:Histamine H3 inverse agonists and antagonists and methods of use thereof
    发明人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN; SPEAR KERRY L
    权利人:CHYTIL MILAN; ENGEL SHARON R; FANG QUN KEVIN; SPEAR KERRY L; SUNOVION PHARMACEUTICALS INC
    摘要:Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.

    专利号:US-7250410-B2
    优先权日:2001-06-07
    标题:Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    发明人:BOURGUIGNON JEAN-JACQUES; LAGOUGE YAN; LUGNIER CLAIRE; KLOTZ EVELINE; MACHER JEAN-PAUL; RABOISSON PIERRE; SCHULTZ DOMINIQUE
    权利人:VIA PHARMACEUTICALS INC
    摘要:The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates. The inventive compounds more particularly correspond to general formula (I):

    专利号:CN-111892519-A
    优先权日:2020-08-12
    标题:Synthesis method of diaryl disulfide compound
    北京普瑞东方化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjpurechem.com
    企业联系电话:010-83993285👤
    📞北京普瑞东方化学技术有限公司 ⚠️参考联系方式
    联系人:冷先生
    电话:010-83993285
    手机:17610176018
    传真:010-63370219
    邮箱:sales@bjpurechem.com
    通信地址: 北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    邮编: 100048
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Harsanyi, A.; Sandford, G., Science of Synthesis Knowledge Updates, (2015) 1, 164.
    摘要:McMurtrey, K. B.; Sanford, M. S., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 553.
    摘要:Kalyani, D.; Desai, L. V., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 3, 739.
    摘要:Xiao, X., Science of Synthesis: Knowledge Updates, (2023) 2, 199.
    摘要:Migliorini, F.; Puglioli, S.; Neri, D.; Cazzamalli, S.; Favalli, N., Science of Synthesis: DNA-Encoded Libraries, (2024) nan, 108.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知